Anyone who has contracted the coronavirus knows that symptoms can linger, and severe symptoms can lead to hospitalization and death. Since the early 2020s when the virus first emerged at large scale, hundreds of scientific studies have been done to better understand the nature of COVID, and the risk factors for severe symptoms, in order to find the most effective ways to treat the virus.
One common denominator that has emerged from multiple research studies and articles on COVID is the importance of nicotinamide adenine dinucleotide (NAD+), an essential molecule that plays a critical role in multiple metabolic processes, including cellular metabolism. Learn what the latest science has to say about NAD levels in COVID patients, and how NAD IV therapy can help you optimize your own NAD levels.
Populations at Highest Risk for Severe COVID
It took months of intensive research and accumulated data to identify risk factors that put certain people with COVID in hospitals, and led many to their deaths. It is now clear that certain populations are more vulnerable and likely to succumb to COVID’s worst symptoms.
According to the US Centers for Disease Control and Prevention (CDC) risk factors for hospitalization and death include one or more co-existing health conditions.
The greatest risk factors for COVID death are:
- Obesity and sedentary lifestyle
- Advanced age
- Chronic high blood pressure
- Fear and anxiety
- Type II diabetes
- Smoking
- Pre-existing chronic disease
- Vitamin D deficiency
It is important to note that risks of death increase with the number of co-existing conditions, and with advanced age.
According to the CDC’s extensive database, the vast majority of COVID deaths — a whopping 97%— occurred in people with two or more coexisting medical conditions, and the overwhelming majority of deaths occurred in people over age 75.
In addition, low Vitamin D levels have been linked to higher risk of hospitalization and death from COVID. Normal-weight people who are physically active are at extremely low risk for severe COVID symptoms. Healthy active people also tend to have higher levels of NAD.
What the Research Says About NAD Therapy and COVID
There is a massive body of evidence-based research on COVID risk factors, with a plethora of findings that link severe symptoms to lifestyle factors.
- A literature review published in November 2020 makes the case that deficient NAD levels in the elderly, obese and type 2 diabetics is strongly correlated with COVID mortality. The research team suggests that nutritional support with NAD therapy can potentially reduce COVID severity when used both preventively and as a therapeutic strategy.
- Another review of studies published in June, 2021 concluded that treatment with combined metabolic activators (CMAs) made up of glutathione and NAD+ precursors leads to rapid symptom-free COVID rehabilitation.
- A third scientific review makes a compelling case that supplementing with nicotinamide riboside, an NAD precursor, can boost natural immunity, significantly reduce COVID recovery time, and potentially break the chain of COVID transmission.
These are just a few of the many studies that support the use of NAD therapy as a preventive and therapeutic treatment for COVID.
NAD IV Drip Therapy vs Oral NAD Supplementation
Oral NAD supplements can vary in potency and efficacy, and some may do nothing at all. In addition, much of NAD’s potency can be lost during the digestive process. Oral supplements often do not break down completely during digestion, and they may be flushed from your body before they can be fully absorbed.
When you supplement with NAD via IV drip, you can rest assured that NAD’s full potency is delivered directly to your bloodstream and carried to the cells that need it most.
NAD IV Therapy in NYC
High-density populations in cities are at higher risk for contracting and spreading COVID, simply because of people’s close proximity to one another. Mask-wearing and social distancing have proven to be ineffective against stopping the spread of COVID, and vaccines and boosters have failed to stop contraction and transmission.
Evidence is clear that healthy people have a lower rate of contraction, significantly milder symptoms, faster recovery, and reduced risk of transmission. Contact InvitaCyoNYC today, and boost your natural immunity with Vitamin D, glutathione and NAD IV therapy, to ward off COVID and avoid severe infection.
Resources
Altay, Ozlem, et al. “Combined metabolic activators accelerates recovery in mild-to-moderate COVID-19.” Advanced Science 8.17 (2021): 2101222.
CDC: Characteristics of Adults Hospitalized With COVID-19 in Premier Healthcare Database Special COVID-19 Release (PHD-SR), March 2020–March 2021
Gharote, Mukul Arvind, and Oliver Patrick Ennis. “Potential Role of Nicotinamide Supplementation in Prevention of Global Covid-19 Transmission.” J Clin Case Rep On 1.1 (2021): 1008.
Miller, R., A. R. Wentzel, and G. A. Richards. “COVID-19: NAD+ deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on SIRT1 activity.” Medical hypotheses 144 (2020): 110044.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322475/
